In Pro Active article 13/3/1914 Mar 2019 08:25
Slimmed-down Integumen looking to AI for next stage of Labskin’s evolution.
Brandon says the combination of Labskin-on-a-chip and Labskin AI should take Integumen to the next level as it is a combination of scaling as a software rather than a physical operation only, and he is targeting 150 companies with revenue in excess of £500mln.
That might sound ambitious, but Brandon reckons it is far from impossible.
“There are 3,685 companies that are large enough in the world to fit within that category. So, 150 is more than achievable.”
The near-500% rise in the share price since his arrival would suggest that the market shares his optimism for the future.